Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Tony B Awardee
Food/Beverage Available
Data Science and AI Parallel Path
Lab Automation Parallel Path
Home
Type here to filter the list
Tuesday, May 28th
11:30 – 13:00
CEST
The New Automation, Decentralization and Point Of Care
Room/Location: 111
Ricard Martin, MBA (he/him/his)
– QIAGEN
Screening Applications & Diagnostics
Tuesday, May 28th
11:30 – 12:00
CEST
The Past, Present and Future of Point of Care Diagnostics
Room/Location: 111
Ayden Malekjahani, ECCMID speaker 2023
– EY-Parthenon
Screening Applications & Diagnostics
Tuesday, May 28th
12:00 – 12:30
CEST
Mobile Analytical Anticounterfeiting Drug Screening Device for Patient Safety
Room/Location: 111
Dominik G. Rabus, PhD (he/him/his)
– RABUS.TECH
Screening Applications & Diagnostics
Tuesday, May 28th
12:30 – 13:00
CEST
Challenging the status quo with Molecular Syndromic Testing
Room/Location: 111
Ricard Martin, MBA (he/him/his)
– QIAGEN
Screening Applications & Diagnostics
Tuesday, May 28th
14:30 – 16:00
CEST
The next big pandemic: Sepsis and Antibiotic Resistance Management, an increasing need for better screening and diagnostics
Room/Location: 111
Enrique Hernández Jiménez, PhD
– Loop Diagnostics S.L.
Screening Applications & Diagnostics
Tuesday, May 28th
14:30 – 15:00
CEST
Enhancing Sepsis Recognition and Treatment: A Multifaceted Personalized Approach
Room/Location: 111
Hjalmar Bouma, MD, PhD, EuCP (he/him/his)
– University Medical Center Groningen
Screening Applications & Diagnostics
Tuesday, May 28th
15:00 – 15:30
CEST
Transforming point-of-care diagnostics: The power of silicon plasmonic biosensors in the battle against acute infections
Room/Location: 111
Dimitris Tsiokos
– Bialoom Ltd
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Tuesday, May 28th
15:30 – 16:00
CEST
Integration of wide-field imaging system with droplet microfluidics for monitoring living bacteria
Room/Location: 111
Sunghyun Ki (he/him/his)
– Incheon National University
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Award Winner
Wednesday, May 29th
11:30 – 13:00
CEST
AI, Machine learning and Big data on the rise for Screening and Diagnostics
Room/Location: 111
Steve Shih, PhD (he/him/his)
– Concordia University
Screening Applications & Diagnostics
Wednesday, May 29th
11:30 – 12:00
CEST
Translational Application of Nanostructured Biosensors: Diagnostics at the Point of Care
Room/Location: 111
Sara Mahshid, Canada Research Chair
– Department of Bioengineering, McGill University
Screening Applications & Diagnostics
Wednesday, May 29th
12:00 – 12:30
CEST
An Automated High-Throughput Platform for AI-Guided Development of Nanopore Membrane Biosensors and Real-time Edge Processing
Room/Location: 111
Shitanshu Devrani, Btech, MSc
– University of Gothenburg
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Award Winner
Wednesday, May 29th
12:30 – 13:00
CEST
Machine learning and digital microfluidics - a new route for high-throughput studies
Room/Location: 111
Steve Shih, PhD (he/him/his)
– Concordia University
Screening Applications & Diagnostics
Data Science and AI Parallel Path
Wednesday, May 29th
14:30 – 16:00
CEST
The Sequencing revolution
Room/Location: 111
Jessica Nordlund, MSc, PhD (she/her/hers)
– SciLifeLab, Uppsala University
Screening Applications & Diagnostics
Wednesday, May 29th
14:30 – 15:00
CEST
A brief History of four Generations of Sequencing Technologies and their Impact on the World
Room/Location: 111
Ivo G. Gut, PhD (he/him/his)
– Centro Nacional de Análisis Genómico (CNAG)
Screening Applications & Diagnostics
Wednesday, May 29th
15:00 – 15:30
CEST
Assaying drug response on patient biopsies and screening hundred thousands of antibodies in one go – the magic of microfluidics
Room/Location: 111
Christoph Merten
– EPFL, The Swiss Federal Institute of Technology of Lausanne
Screening Applications & Diagnostics
Wednesday, May 29th
15:30 – 16:00
CEST
NGS-BASED PROTEOMICS DRIVES A SYSTEMATIC APPROACH TO IDENTIFY CAUSAL THERAPEUTIC TARGETS IN LARGE POPULATION HEALTH COHORTS LIKE THE UK BIOBANK
Room/Location: 111
Cindy Lawley, PhD (she/her/hers)
– Olink Proteomics
Screening Applications & Diagnostics